Previous studies have revealed that ATG5 polymorphisms are linked to a wide range of immune-mediated and autoimmune diseases, including multiple sclerosis [5], systemic lupus erythematosus [6], and rheumatoid arthritis [7]. Here, ATG5 is linked to systemic lupus erythematosus.